SCALE-UP AND TECHNICAL TRANSFER FOR LYOPHILIZED PRODUCTS
Publisher: Baxter BioPharma Solutions
Access this content
Your content has been opened.
SCALE-UP AND TECHNICAL TRANSFER FOR LYOPHILIZED PRODUCTS has been emailed to . Entered the wrong email?
Don't see the content in your inbox?
Make sure to check your spam and other messages folders.
Can't get to your email right now?
To complete your registration and access this content, enter the sign-in code sent to your email.
Please enter a valid verification code.
Code sent to:
Register to access this content
By accessing content on the Pharmaceutical Manufacturing Resource Directory you agree to our Terms of Service and Privacy Policy; and, you acknowledge that your information may be shared with the content publisher.
Formulation and process development for injectable products are typically conducted at laboratory-scale. There are few challenges when increasing the scale of production for a solution formulation, but the challenges drastically increase when the formulation is intended for lyophilization. The process is transferred to full-scale freeze dryers that can be 10 times the size of the laboratory-scale equipment. This whitepaper from Baxter BioPharma Solutions addresses these challenges by: • Examining the different designs for lyophilizers • Discussing the in-process data collected during freeze-drying • Presenting a method of determining equipment capability and comparing data between lab-scale and full-scale equipment Considering the differences in equipment design and capability will aid in the scale-up and technical transfer of new processes from laboratory-scale to full-scale and in transfers between manufacturing sites.
Similar content you might be interested in
